relevant papers could be retrieved. A total of eight qualitative research papers and one mixed methods paper were selected that met the eligibility criteria. These papers were then critically appraised using CASP's critical appraisal tool and analysed using thematic analysis. Results: Nine studies involving 105 carers were included in this review. All studies utilised semi-structured interviews to gather data. The studies were conducted in the United Kingdom (n ¼ 3), Canada (n ¼ 1), Sweden (n ¼ 1), Australia (n ¼ 2), Ireland (n ¼ 1) and America (n ¼ 1). From the thematic analysis four themes emerged from the data set identifying the specific challenges HNC carers faced; challenges due to new roles and responsibilities, information challenges, support challenges and relationship challenges. Conclusions: This review identified the specific challenges experienced by carers of individuals diagnosed with HNC. The multiple caregiving responsibilities they undertake, impacted both their physical and emotional wellbeing. Furthermore, these challenges were found to be exacerbated by the inadequate provision of information and support facilitated by healthcare professionals. Awareness of these extensive challenges will help to identify ways of supporting carers in adapting to their new roles and responsibilities. Results may also guide development of future interventions and strategies aimed at providing information and psychosocial support for carers. Legal entity responsible for the study: Charlotte Johnston. The objective of this study was to evaluate any unmet needs of support and information for patients on Phase I trials. The aim was to utilise patient exerience to assess the need to change or develop delivery of information and support. Methods: A qualitative approach was used. Patients and relatives of patients with cancer on Phase I trials formed two focus group. Group 1 consisted of 8 participants and group 2 10 participants, both lasted one hour. A semi structured schedule was used to prompt discussion, the focus groups were audio-recorded and transcribed verbatim. The data were organised using the Nvivo software package and analysed using Braun and Clarke's thematic analysis framework. Results: Four themes emerged from the data 1) face to face support; there was a general consensus that the best way to recieve information about treatment and disease was face to face. The relationships with the clinical staff were strong and important to maintain. At times when the trials unit was not accessible patients felt vulnerable 2) remote support; email was felt to be a good way to communicate information regarding appointments, the telephone clinic was useful for contact regarding sympton issues. Digital methods of information and support were potentially useful but needed to be thought through properly 3) getting the right information, at the right time , in the right way; patients felt that they needed extra information particularly in terms of feedback regarding the trials and signposting to support services 4) Relationships with other patients; this theme was about the benefit and value patients had in supporting each other within the treatment areas, however this was conflicted and may require extra support at times as there was a negative impact when fellow patients became unwell or died.
Background: Advances in the understanding of the biological basis of cancer have resulted in a paradigm shift in drug development. Phase I trials with translational elements are conducted in clinical trials units for patients with cancer. The objective of this study was to evaluate any unmet needs of support and information for patients on Phase I trials. The aim was to utilise patient exerience to assess the need to change or develop delivery of information and support. Methods: A qualitative approach was used. Patients and relatives of patients with cancer on Phase I trials formed two focus group. Group 1 consisted of 8 participants and group 2 10 participants, both lasted one hour. A semi structured schedule was used to prompt discussion, the focus groups were audio-recorded and transcribed verbatim. The data were organised using the Nvivo software package and analysed using Braun and Clarke's thematic analysis framework. Results: Four themes emerged from the data 1) face to face support; there was a general consensus that the best way to recieve information about treatment and disease was face to face. The relationships with the clinical staff were strong and important to maintain. At times when the trials unit was not accessible patients felt vulnerable 2) remote support; email was felt to be a good way to communicate information regarding appointments, the telephone clinic was useful for contact regarding sympton issues. Digital methods of information and support were potentially useful but needed to be thought through properly 3) getting the right information, at the right time , in the right way; patients felt that they needed extra information particularly in terms of feedback regarding the trials and signposting to support services 4) Relationships with other patients; this theme was about the benefit and value patients had in supporting each other within the treatment areas, however this was conflicted and may require extra support at times as there was a negative impact when fellow patients became unwell or died.
Conclusions: Based on the results from the analysis written patient information was redesigned. A quarterly forum is in development where patients can meet recieve well being advice and also feedback regarding the trials they are participating in. Legal entity responsible for the study: Royal Marsden NHS Foundation Trust. Nursing, National and Kapodistrian University of Athens, Athens, Greece, 2 Palliative Care Unit Galilee, Palliative Care Unit Galilee, Spata, Greece
Background: A core concept in caring patients with advanced cancer is to treat them and preserve dignity independently the service of care. This cross-sectional study's purpose was to explore the dignity of patients with advanced cancer. Methods: A convenience sample of 99 (response rate 85%) patients with advanced cancer was recruited between April to December 2017 by a palliative care unit (PCU) (day (PDC) and home care (PHC)) and oncology units (chemotherapy outpatient (OU) and inpatient (IU)) of Athens. Patients with advanced cancer (stage III or IV) who consented, completed the Patient Dignity Inventory (PDI), a 25 items scale, 5 point Likert scale (1 (no problem) -5 (overwhelming problem) divided into: Symptom (SD) and Existential distress (ED), Peace of Mind (PM), Dependency (D), and Social Support (SS). Also Hospital Anxiety and Depression Scale (HADS), Edmonton Symptom Assessment Scale -short version and a demographic/ clinical form were collected. Results: Most patients were female (54.5%), the mean age was 64.9 years. Breast (22.2%), colorectal (16.2%) and lung cancer (15.2%) were the most frequent diagnoses. Almost half patients (56.6%) were hospitalized (36.4% OU, 20.2% IU) and the others were cared for at the PCU (28.2% PHC, 15.2% PDC). The PDI mean scores were: Total Dignity (TD) 50.2 (25-125), SD 15.3 (6-30), ED 12.7 (6-30), PM 4.7 (3-15), D 5.8 (3-15), SS 4.5 (3-15). Most of the demographic and clinical characteristics were not associated with total or subscales scores of PDI. On the other hand, women (p¼.035) and breast cancer patients reported less SS (p¼.022). The OU patients reported better TD (p¼.029), SD (p¼.001), ED (p¼.002) and D (p¼.003) than OU and PHC but not PDC. Higher scores of TD were significantly correlated with experience of pain, tiredness, lack of appetite, shorten of breath, anxiety and depression (p<.006). Reports of anxiety and depression measured by HADS were correlated with higher total and subscales dignity scores (.001 < p < .006). Conclusions: The findings of this study support a quite good level of perceived dignity in Greek patients with advanced cancer. More research is needed to clarify the differences of dignity among various care settings. We thank Special Account for Research Grants and National and Kapodistrian University of Athens. Legal entity responsible for the study: Nursing Department, National and Kapodistrian University of Athens. Background: Lifestyle habits such as tobacco use, alcohol consumption, insufficient physical activity, sun exposure and unhealthy eating habits are risk factors for cancer but also increase the risk of side-effects and poor outcome from cancer treatments. The Swedish Cancer Nursing Society initiated and developed a multi-professional project where they adapted the current national guidelines for lifestyle habits of preventing disease (by National Board of Health and Welfare), to the cancer context. Methods: The project includes developing written guidelines for staff and an evidencebased educational program for cancer contact nurses (CNs). The CNs has a unique position to inform and support patients and their families on lifestyles changes. The education program (one full day training and one half day follow-up) started in May 2018 and includes lectures and case discussions that cover all cancer related lifestyle issues. It also includes systematic assessment and models for change. All Swedish CNs (approx. 1000) will be invited to participate. Results: A first evaluation of the program will be presented during EONS11 at ESMO 2018. Data will be collected via surveys and interviews with CNs and also from cancer care provider data sources (on what lifestyle interventions that have been delivered to patients). Conclusions: The project will be on the way to implement evidence-based knowledge about lifestyle habits to CN. Legal entity responsible for the study: Swedish Nurses Oncological Associations. Background: Metastatic breast cancer (SBC) is now seen as a chronic disease, however the number of patients currently living with SBC is unknown. Despite widespread recognition of the importance of understanding and evaluating patients' experiences, little research has been undertaken within SBC. Generally, there has been significant expansion in the development and application of patient reported questionnaires that measure care experiences (PREM), which is a major indicator of healthcare quality, however there is no specific PREM for people with SBC.
Methods: This study aims to develop and pilot test a unidimensional PREM in SBC for clinical application using a mixed methods sequential exploratory design. Semi-structured interviews were conducted with 25 people with SBC to explore their experiences, priorities and needs diagnosis of metastatic disease and during palliative treatment. Potential items for PREM-SBC were extracted from interview data focusing on patients' experiences and priorities for care. Cognitive interviews were undertaken with patients to ensure all items listed were clear and easily understood. Results: Following cognitive interviews a draft PREM questionnaire was created for patients with SBC. The structured questionnaire contains 48 items (statements) based on patients' experiences, treatment / care, priorities and needs. A five point scale is used to rate each item from strongly agree to strongly disagree. Patients report the PREM is easy to complete, taking less than 5 minutes. Further pilot testing is currently being undertaken (n ¼ 130) to assess the validity, reliability and repeatability of PREM-SBC, drawing comparisons with other quality of life measures. Conclusions: There is currently a lack of research focusing on patients with SBC. A draft PREM-SBC questionnaire was developed and pilot tested for clinical use. This will increase understanding of patients' experiences, needs and priorities to enhance patient care.
Legal entity responsible for the study: The Christie NHS Trust. Funding: Roche. Disclosure: All authors have declared no conflicts of interest.
